U.S. Markets closed

Repligen Corp (RGEN) CEO Anthony Hunt Sold $996,546 of Shares

CEO of Repligen Corp (30-Year Financial, Insider Trades) Anthony Hunt (insider trades) sold 12,094 shares of RGEN on 09/09/2019 at an average price of $82.4 a share. The total sale was $996,546.


Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen Corp has a market cap of $4.12 billion; its shares were traded at around $79.88 with a P/E ratio of 142.65 and P/S ratio of 16.15. Repligen Corp had annual average EBITDA growth of 5.70% over the past five years. GuruFocus has detected 3 severe warning signs with Repligen Corp. .

CEO Recent Trades:

  • CEO Anthony Hunt sold 12,094 shares of RGEN stock on 09/09/2019 at the average price of $82.4. The price of the stock has decreased by 3.06% since.

For the complete insider trading history of RGEN, click here

.This article first appeared on GuruFocus.